Table 2.

Proteins identified in at least 3 ovarian cancer studies as reported by Kulasingam et al. (21) and have known ratios of 1 year hormone therapy compared to baseline

ProteinLog2 ratio (1 year HT/baseline)P
A2M0.070.13
C30.130.0011
CFB0.182.86E-05
CFI0.0920.0059
CLU0.0870.00094
COL1A1−0.776.80E-05
FBLN1−0.0321.00
GRN0.0680.42
IGFBP2−0.340.025
IGFBP40.350.010
LGALS10.210.09
LTBP1−0.100.16
NPC20.030.29
PROS1−0.110.07
SERPING10.470.012
TGFBI0.310.0035
THBS10.230.24
VASN−0.390.0044
VTN0.678.31E-09
WFDC2−0.0550.97

Abbreviation: HT, hormone therapy.